Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Appointment of Mr Narahari Naidu as Chief Financial Officer of the company w.e.f. August 04, 2025.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 13.2 pts more than Nifty Microcap 250 and 13.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sanofi Consumer Healthcare India has appointed Mr. Narahari Naidu as its Chief Financial Officer, effective August 4, 2025, for an initial term of six months. The appointment was approved by the Board based on the recommendation of the Nomination and Remuneration Committee and in consultation with the Audit Committee. Mr. Naidu brings over 14 years of experience across healthcare, manufacturing, and consulting sectors, with prior expertise in finance, M&A, investor relations, treasury, and IPO management. He most recently served as Group CFO for entities operating across India, the UK, and the USA.
The appointment fills a key financial leadership role at the company. The short initial term of six months suggests this may be an interim arrangement, which investors may want to monitor for a longer-term successor announcement.